Alternatives to Deep Genomics

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

AI-powered insights platform for life sciences and biotech workflows.

AI-driven diagnostics that convert medical images into actionable genomic insights for faster cancer treatment decisions.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

AI-powered platform for antibody discovery and development to create new medicines.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered platform for understanding disease biology and accelerating drug discovery.

AI-guided drug discovery platform for tissue-targeted medicines.

AI-powered platform for real-time organ physiology to accelerate human-relevant drug discovery.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

Mapping cell-cell communication at scale in human tissue.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.